Navigation Links
Impotence drug such as Viagra may cause Vision Loss

Impotence drug such as Viagra use is linked to development of vision disorders. It is found that 19% of people with// vision disorders have used Viagra medicines. It is found that it contains three phosphodiesterase 5 (PDE5) inhibitors which is found to cause risk of blindness. Men most at risk for the vision loss are those older than 50 who have diabetes, heart disease, high blood pressure and high cholesterol, among other ailments. The US consumers groups want the impotence drug to carry 'Strong Warning Labels' which mentions about the side effects of these drugs. Even doctors and pharmacists are not aware of the side effects caused by the drug so, letters should be sent to doctors regarding the risk of blindness due to impotence drugs. Earlier this year drug makers agreed to put information on their impotence drug labels about the possible vision loss, called non-arteritic anterior ischemic optic neuropathy.

U.S. consumer group Public Citizen said on Thursday in a petition filed with health regulators that 'U.S. Food and Drug Administration should immediately, add a black box warning regarding the risks of drug-induced blindness for the three phosphodiesterase 5 (PDE5) inhibitors that are prescribed for the treatment of erectile dysfunction'.

Pharmaceutical Company:
Pfizer Inc.'s pulmonary hypertension drug Revatio, which has the same active ingredient as its impotence drug Viagra, should also carry a similar black box warning, the strongest warning the agency can require, the advocacy group said. Viagra, Cialis, sold by Eli Lily & Co. and Icos Corp. and Levitra, sold by GlaxoSmithKline, Bayer AG and Schering-Plough Corp. now carry the new labels, which say the condition "has been reported rarely. Both the companies and the FDA have said the cause of the blindness is not known.

Public Citizen:
The Public Citizen petitioner said, 'The fact that Viagra's large numbers of adverse reaction reports occurred with out any warnings to the medical profession strongly suggests that Viagra is an important factor in causing (ischemic optic neuropathy) and the wordings in the drug label is ambiguous and the location of this information is buried'

Public Citizen also called on the FDA to start a registry of all patients who are diagnosed with the vision disorder. The agency should also require manufacturers to send all U.S. physicians a letter about the risk and call for pharmacists to give FDA-approved leaflets with prescriptions.

Charles Grassley, Iowa Republican, Senate Finance Committee Chairman has questioned the FDA regarding the actions taken by them against the reports of blindness due to use of Impotence drugs and other information’s and why it had taken so long for the FDA to give necessary actions to the pharmaceutical companies regarding change of labels and informing the public.

(Reuters 2005)

Information on Side effects of Viagra in Medindia:

With viagra, the most common side effects are headache, facial flushing, and upset stomach. It may also briefly cause bluish or blurred vision, or sensitivity to light. In the rare event of an erection lasting more than 4 hours, seek immediate medical help. Remember to protect yourself and your partner from sexually transmitted diseases
'"/>




Related medicine news :

1. Gene Therapy could treat Impotence
2. Impotence Drugs Ordered by FDA to have Label Change
3. Satisfied Sexual Intercourse for Impotence men with Penile Prosthesis
4. Young Men Face Impotence Problems As Well
5. Impotence May be a Sign of Heart Disease, Diabetes
6. Happy Impotence Day
7. Viagra for heart and lung patients
8. Viagra Also Found To Be Effective For Treatment of Lung Diseases
9. The Use Of Viagra for Babies Questioned
10. Viagra Used More By Young Men
11. Treating Altitude Sickness With Viagra
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
(Date:7/20/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of ... up with a Microsoft Corp. employee-led hackathon team for the 2017 Microsoft One Week ... Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every person and every ...
(Date:7/20/2017)... ... July 20, 2017 , ... Girl Up Campaign Director, Melissa ... legislation in support of providing girls access to education in refugee settings. In May, ... “Protecting Girls’ Access to Education in Vulnerable Settings Act.” Yesterday, companion legislation was ...
(Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced today ... existing adherence automation lines. The ATP® Mini and InspectRx® Mini are ... standard products, but at a size and price point that can help pharmacies ...
(Date:7/20/2017)... ... July 20, 2017 , ... With ... 2014, top travel insurance solution company VisitorsCoverage Inc. has launched TMQuotes, a new ... international travel insurance products online, under their own brand. The online marketplace bridges ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... 2017  Sysmex America, Inc., a leading provider ... as well as middleware information systems technology, today ... quality assurance easier and more risk free than ... for the innovation that it delivers to the ... assurance processes to a new level with automated, ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
Breaking Medicine Technology: